1. Sulfated Chitosan-Modified CuS Nanocluster: A Versatile Nanoformulation for Simultaneous Antibacterial and Bone Regenerative Therapy in Periodontitis.
- Author
-
Chen X, Huang N, Wang D, Zhang M, Deng X, Guo F, Yi B, Yuan C, and Zhou Q
- Subjects
- Animals, Rats, Rats, Sprague-Dawley, Male, Sulfates chemistry, Sulfates pharmacology, Silicon Dioxide chemistry, Silicon Dioxide pharmacology, Microbial Sensitivity Tests, Chitosan chemistry, Chitosan pharmacology, Periodontitis drug therapy, Periodontitis microbiology, Periodontitis therapy, Periodontitis pathology, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents chemistry, Bone Regeneration drug effects, Copper chemistry, Copper pharmacology, Fusobacterium nucleatum drug effects, Nanoparticles chemistry
- Abstract
Periodontitis, a prevalent chronic inflammatory disease worldwide, is triggered by periodontopathogenic bacteria, resulting in the progressive destruction of periodontal tissue, particularly the alveolar bone. To effectively address periodontitis, this study proposed a nanoformulation known as CuS@MSN-SCS. This formulation involves coating citrate-grafted copper sulfide (CuS) nanoparticles with mesoporous silica (MSNs), followed by surface modification using amino groups and sulfated chitosan (SCS) through electrostatic interactions. The objective of this formulation is to achieve efficient bacteria removal by inducing ROS signaling pathways mediated by Cu
2+ ions. Additionally, it aims to promote alveolar bone regeneration through Cu2+ -induced pro-angiogenesis and SCS-mediated bone regeneration. As anticipated, by regulating the surface charges, the negatively charged CuS nanoparticles capped with sodium citrate were successfully coated with MSNs, and the subsequent introduction of amine groups using (3-aminopropyl)triethoxysilane was followed by the incorporation of SCS through electrostatic interactions, resulting in the formation of CuS@MSN-SCS. The developed nanoformulation was verified to not only significantly exacerbate the oxidative stress of Fusobacterium nucleatum , thereby suppressing bacteria growth and biofilm formation in vitro , but also effectively alleviate the inflammatory response and promote alveolar bone regeneration without evident biotoxicity in an in vivo rat periodontitis model. These findings contribute to the therapeutic effect on periodontitis. Overall, this study successfully developed a nanoformulation for combating bacteria and facilitating alveolar bone regeneration, demonstrating the promising potential for clinical treatment of periodontitis.- Published
- 2024
- Full Text
- View/download PDF